NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » GE Healthcare, Indi Molecular to develop immune cell-targeted PET tracer candidates » Indimolecular

GE Healthcare, Indi Molecular to develop immune cell-targeted PET tracer candidates

NS Medical Devices is using cookies

Image: GE Healthcare and Indi Molecular have collaborated to develop immune cell-targeted PET tracer candidates. Photo: courtesy of General Electric.

Related Article

Biggest players in the global wound care market

RECOMMENDED COMPANIES

MOST READ

Blue Arbor secures FDA Breakthrough Device Designation for RESTORE System

Angle partners with AstraZeneca to develop advanced cancer assay

United Therapeutics conducts first transplant of UThymoKidney

RenovaroCube to fully acquire molecular biology firm Cyclomics

Exo introduces new cardiac and lung AI applications on Exo Iris

Recommended Whitepaper